Mechanical Circulatory Support in Patients with Cardiogenic Shock after Surgical Revascularization.

This article discusses the use of mechanical circulatory support in patients with cardiogenic shock after surgical revascularization. The study evaluated the survival rates of patients who received va-ECMO treatment in a center for surgical revascularization. The results showed that 30-day survival was 53.1%, and there were no significant differences in patient age, gender, and ECMO runtime for survival. The use of vasopressin was higher in the nonsurvival population, and survival patients had a significantly longer hospital stay. The authors conclude that ECMO support may be beneficial for selected patients after surgical revascularization. [Extracted from the article]